Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Recent studies using magnetic resonance spectroscopy have shown that decreased insulin-stimulated muscle glycogen synthesis due to a defect in insulin-stimulated glucose transport activity is a major factor in the pathogenesis of type 2 diabetes. The molecular mechanism underlying defective insulin-stimulated glucose transport activity can be attributed to increases in intramyocellular lipid metabolites such as fatty acyl CoAs and diacylglycerol, which in turn activate a serine/threonine kinase cascade, thus leading to defects in insulin signaling through Ser/Thr phosphorylation of insulin receptor substrate (IRS)-1. A similar mechanism is also observed in hepatic insulin resistance associated with nonalcoholic fatty liver, which is a common feature of type 2 diabetes, where increases in hepatocellular diacylglycerol content activate protein kinase C-ε, leading to reduced insulin-stimulated tyrosine phosphorylation of IRS-2. More recently, magnetic resonance spectroscopy studies in healthy lean elderly subjects and healthy lean insulin-resistant offspring of parents with type 2 diabetes have demonstrated that reduced mitochondrial function may predispose these individuals to intramyocellular lipid accumulation and insulin resistance. Further analysis has found that the reduction in mitochondrial function in the insulin-resistant offspring can be mostly attributed to reductions in mitochondrial density. By elucidating the cellular and molecular mechanisms responsible for insulin resistance, these studies provide potential new targets for the treatment and prevention of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DAGs have been reported to reduce insulin sensitivity in skeletal muscle (25).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [25]
In the citing paper
“These traits are most often observed in association with aging, severe obesity and type 2 diabetes but were also evident in young insulin-resistant offspring of parents with diabetes [60,62].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [60]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [17]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The World Health Organization estimates that by the year 2030, 366 million people will be afflicted with diabetes (1).”
BackgroundMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“Downstream molecules such as phosphatidylinositol-dependent kinase (PDK) and protein kinase B (PKB [AKT]) have a pleckstrin homology domain that enables these molecules to migrate toward the plasma membrane (28).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Using a similar approach, we used (31)P MRS to examine mitochondrial function in young lean insulin-resistant offspring of parents with type 2 diabetes (20).”
BackgroundMethodSelf-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Using (13)C/(31)P MRS, we directly assessed mitochondrial oxidative and phosphorylation activity in the healthy lean elderly volunteers with severe muscle insulin resistance and found that they have an 40% reduction in rates of oxidative phosphorylation activity associated with increased intramyocellular and intrahepa…”
MethodSelf-citation
Cited by
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
“…via glutamate transamination to alanine. contributing to accumulation of lipid-derived metabolites such as diacylglyerols, ceramides, ketones, prostaglandins, and incompletely oxidized lipids that can impact insulin signaling (Muoio and Newgard, 2008; Morino et al., 2006; Summers, 2006).”
BackgroundInflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundRole of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602
“Skeletal muscle is one of the primary tissues responsible for insulin stimulated glucose uptake and reduced mitochondrial function has been shown to play an important role in the development of insulin resistance with obesity (Morino et al., 2006; Wallace, 2005).”
BackgroundOxidative stress, insulin signaling, and diabetes
Rains, J. L., & Jain, S. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.006 · Cited by 1,435
“These include ROSimpaired insulin signaling caused by inducing IRS serine/threonine phosphorylation, disturbing cellular redistribution of insulin signaling components, decreasing GLUT4 gene transcription, and altering mitochondrial activity [11,43].”
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
Self-citationRole of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Varga, T., Czimmerer, Z., & Nagy, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.014 · Cited by 933
“The lipotoxicity theory [14] proposes that when the fat storing capacity of the adipose tissue is chronically overloaded, fatty molecules will be deposited in other tissues, including muscle and liver.”
BackgroundAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
“Furthermore, the intermediate diacylglycerol, which accumulates during de novo lipogenesis activates hepatic protein kinase C e type (PKCe)”
BackgroundThe randle cycle revisited: a new head for an old hat.
Hue, L., & Taegtmeyer, H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2009 · Cited by 743
Sugar consumption, metabolic disease and obesity: The state of the controversy
Stanhope, K. L. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1084990 · Cited by 739
“Increased levels of hepatic lipids may also promote hepatic insulin resistance (39), possibly by increasing levels of diacylglycerol (DAG), which activates novel protein kinase C (nPKC) and leads to serine phosphorylation of the insulin receptor and insulin receptor substrate 1 (IRS-1) and impaired insulin action (40).”
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
“The recent studies have reported the existence of a defect in mitochondrial oxidative phosphorylation in skeletal muscle in insulin resistance states [16–20] and suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
BackgroundAMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
“Insulin-resistant states are associated with increased production of ROS, and reduction of ROS with antioxidants improves insulin sensitivity (39,40).”
BackgroundNon-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
Milić, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9330 · Cited by 583
Bose, M., Lambert, J. D., Ju, J., Reuhl, K. R., Shapses, S. A., & Yang, C. S. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.9.1677 · Cited by 613
“These effects may be mediated through the activation of protein kinase C, which is stimulated by fatty acids and contributes to the phosphorylation of the insulin receptor substrate at Ser-307, resulting in inhibition of normal insulin signaling (32,33).”
BackgroundSchooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616
“Although contested now, cytosolic lipid accumulation was also suggested to arise from mitochondrial dysfunction and, as a consequence, decreased FAO rate (2,9,14,45,46).”
Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density.
Barrès, R., Osler, M. E., Yan, J., Rune, A., Fritz, T., Caidahl, K., Krook, A., & Zierath, J. R. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.011 · Cited by 602
Phosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598
Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
Tabit, C. E., Chung, W. B., Hamburg, N. M., & Vita, J. A. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9134-4 · Cited by 572
“Interestingly, accumulation of diacylglycerol in this setting has been attributed to impaired mitochondrial substrate utilization [165].”
BackgroundHigh-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538
“I t has been hypothesized that insulin resistance in patients with impaired or diabetic glucose tolerance is mediated by a deficiency of mitochondria in skeletal muscle (1, 2).”
BackgroundCauses and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
Metabolic flexibility and insulin resistance
Galgani, J. E., Moro, C., & Ravussin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90558.2008 · Cited by 532
“raised but the causal link between the two still remains to be established (38).”
BackgroundThe metabolic footprint of aging in mice
Houtkooper, R. H., Argmann, C., Houten, S. M., Cantó, C., Jeninga, E. H., Andreux, P. A., Thomas, C., Doenlen, R., Schoonjans, K., & Auwerx, J. (2011) · Scientific Reports · doi:10.1038/srep00134 · Cited by 528
“Increased IRS-1 serine phosphorylation is linked to insulin resistanc”
BackgroundMinireview: Lipid Droplets in Lipogenesis and Lipolysis
Ducharme, N. A., & Bickel, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1713 · Cited by 514
Kumar, K. G., Trevaskis, J. L., Lam, D. D., Sutton, G. M., Koza, R. A., Chouljenko, V. N., Kousoulas, K. G., Rogers, P. M., Kesterson, R. A., Thearle, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.011 · Cited by 511
“While steatosis could be a factor causing insulin resistance, hyperinsulinism exacerbates steatosis by further stimulating lipogenesis (Morino et al., 2006; Perlemuter et al., 2007; Petersen et al., 2007).”
Ertunc, M. E., & Hotamisligil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 488
Kusminski, C. M., Holland, W. L., Sun, K., Park, J., Spurgin, S. B., Lin, Y., Askew, G. R., Simcox, J. A., McClain, D. A., Li, C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2899 · Cited by 470
The potential of endurance exercise-derived exosomes to treat metabolic diseases
Safdar, A., Saleem, A., & Tarnopolsky, M. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.76 · Cited by 463
Optimal protein intake in the elderly
Wolfe, R. R., Miller, S. L., & Miller, K. B. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.008 · Cited by 456
Befroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453
Self-citationMetabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 385
“Indeed, it is not known whether increases in FAO limit IR by decreasing the accumulation of lipids, or whether an increase in oxidative rate can aggravate IR through incomplete FAO products accumulation, such as acylcarnitine [149, 150].”
BackgroundPGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity
Lira, V. A., Benton, C. R., Yan, Z., & Bonen, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00755.2009 · Cited by 412
O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
Insulin resistance in obesity: an overview of fundamental alterations
Barazzoni, R., Gortan Cappellari, G., Ragni, M., & Nisoli, E. (2018) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/s40519-018-0481-6 · Cited by 350
“In humans, lower expression of the key regulator of muscle mitochondrial biogenesis PGC1α as well as reduced mitochondrial function have been described in progeny and first degree relatives of diabetic and insulin-resistant patients [74, 78].”
BackgroundLow-Volume Interval Training Improves Muscle Oxidative Capacity in Sedentary Adults
HOOD, M. S., LITTLE, J. P., TARNOPOLSKY, M. A., MYSLIK, F., & GIBALA, M. J. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182199834 · Cited by 375
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
Snel, M., Jonker, J. T., Schoones, J., Lamb, H., de Roos, A., Pijl, H., Smit, J. W. A., Meinders, A. E., & Jazet, I. M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/983814 · Cited by 368
“Figure 2 describes the effects of intracellular lipid accumulation in skeletal muscle, liver, and cardiomyocytes [18, 19].”
BackgroundInfluentialLipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 352
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
Chung, H. K., Ryu, D., Kim, K. S., Chang, J. Y., Kim, Y. K., Yi, H.-S., Kang, S. G., Choi, M. J., Lee, S. E., Jung, S.-B., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201607110 · Cited by 357
“In humans, the mitochondrial content and oxidative function of skeletal muscle vary widely, and dysfunction of skeletal mitochondria is associated with abnormal nutrient handling typical of insulin resistance (Petersen et al., 2003; Morino et al., 2006; Jelenik and Roden, 2013).”
BackgroundInterleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H. S., Henstridge, D. C., Watson, N., Zaffino, L. A., Babb, J. R., Boon, J., Meikle, P. J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1865-y · Cited by 334
“In the past decade, it has become apparent that insulin resistance is associated with impaired mitochondrial function in skeletal muscle [43].”
BackgroundVascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Gao, L., & Mann, G. E. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp031 · Cited by 329
“Insulin resistance plays a central role in the development of type 2 diabetes and associated cardiovascular complications.(46,47,51,52) In a mouse model of obesity, induced by Table 1 NAD(P)H oxidase homologues”
BackgroundLee, H.-Y., Choi, C. S., Birkenfeld, A. L., Alves, T. C., Jornayvaz, F. R., Jurczak, M. J., Zhang, D., Woo, D. K., Shadel, G. S., Ladiges, W., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.004 · Cited by 319
“These studies support the hypothesis that age-associated reductions in mitochondrial function predispose to intramyocellular lipid accumulation, PKCq activation, and muscle insulin resistance (Lowell and Shulman, 2005; Morino et al., 2006; Petersen et al., 2003).”
Self-citationNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
What is metabolic syndrome, and why are children getting it?
Weiss, R., Bremer, A. A., & Lustig, R. H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12030 · Cited by 307
The Role of Ceramides in Insulin Resistance
Sokolowska, E., & Blachnio-Zabielska, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00577 · Cited by 297
“It was shown that muscle insulin resistance arises from impaired mitochondrial uptake and oxidation of fatty acids (28).”
BackgroundKantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H.-U., et al. (2009) · Diabetes · doi:10.2337/db09-0279 · Cited by 303
“Therefore, increased activity of the protein may also result in depletion in the hepatic DAG and fatty acid content, both of which are involved in lipotoxicity (47,48).”
BackgroundSirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00187 · Cited by 288
Molecular mechanisms of insulin resistance in type 2 diabetes mellitus
Saini, V. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i3.68 · Cited by 288
Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies
Bergouignan, A., Rudwill, F., Simon, C., & Blanc, S. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00698.2011 · Cited by 274
Gallagher, I. J., Scheele, C., Keller, P., Nielsen, A. R., Remenyi, J., Fischer, C. P., Roder, K., Babraj, J., Wahlestedt, C., Hutvagner, G., et al. (2010) · Genome Medicine · doi:10.1186/gm130 · Cited by 297
“[2], a coordinated down-regulation of oxidative phosphorylation related (OXPHOS) genes in the skeletal muscle of patients was the only change reported and this was proposed to be the underlying cause of skeletal muscle insulin resistance [5-7].”
BackgroundZhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291
Self-citationDevelopment of insulin resistance in mice lacking PGC-1α in adipose tissues
Kleiner, S., Mepani, R. J., Laznik, D., Ye, L., Jurczak, M. J., Jornayvaz, F. R., Estall, J. L., Chatterjee Bhowmick, D., Shulman, G. I., & Spiegelman, B. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207287109 · Cited by 287
“M dysfunction in various tissues is associated with the development of type 2 diabetes and insulin resistance (1, 2).”
BackgroundSelf-citationRitov, V. B., Menshikova, E. V., Azuma, K., Wood, R., Toledo, F. G. S., Goodpaster, B. H., Ruderman, N. B., & Kelley, D. E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00317.2009 · Cited by 283
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses
Chen, Y., Yang, M., Huang, W., Chen, W., Zhao, Y., Schulte, M. L., Volberding, P., Gerbec, Z., Zimmermann, M. T., Zeighami, A., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315833 · Cited by 270
Flockhart, M., Nilsson, L. C., Tais, S., Ekblom, B., Apró, W., & Larsen, F. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.017 · Cited by 257
Zhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
“modulate insulin action [6-9].”
BackgroundStanhope, K. L., & Havel, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2b24a · Cited by 269
Lipid droplets as dynamic organelles connecting storage and efflux of lipids
Olofsson, S.-O., Boström, P., Andersson, L., Rutberg, M., Perman, J., & Borén, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.08.001 · Cited by 265
Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance
Beyer, T. A., Xu, W., Teupser, D., auf dem Keller, U., Bugnon, P., Hildt, E., Thiery, J., Kan, Y. W., & Werner, S. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601950 · Cited by 266
Mechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
“The latter ultimately impairs insulin signaling through different mechanisms, either increased serine phosphorylation of IRS1 at Ser-1101 and/or reduced serine phosphorylation of PKB/Akt (Morino et al., 2006; Summers & Nelson, 2005).”
BackgroundEngin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
“Diacylglycerols are well-known allosteric activators of PKC, an enzyme which has been linked to insulin resistance in a variety of rodent models (36,37) as well as in the human liver (36).”
BackgroundAcyl-CoA synthesis, lipid metabolism and lipotoxicity
Li, L. O., Klett, E. L., & Coleman, R. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.024 · Cited by 239
Patel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S., & Singal, P. K. (2016) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 240
Attané, C., Foussal, C., Le Gonidec, S., Benani, A., Daviaud, D., Wanecq, E., Guzmán-Ruiz, R., Dray, C., Bezaire, V., Rancoule, C., et al. (2012) · Diabetes · doi:10.2337/db11-0100 · Cited by 228
“Instead of being directed to the mitochondria, FAs accumulate as DAG, leading to insulin resistance (28,29).”
BackgroundInsulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233
Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
Sangwung, P., Petersen, K. F., Shulman, G. I., & Knowles, J. W. (2020) · Endocrinology · doi:10.1210/endocr/bqaa017 · Cited by 218
Self-citationGupte, A. A., Bomhoff, G. L., Swerdlow, R. H., & Geiger, P. C. (2009) · Diabetes · doi:10.2337/db08-1070 · Cited by 227
The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Farese, R. V., Zechner, R., Newgard, C. B., & Walther, T. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.004 · Cited by 209
“Both classes of kinases might then interfere with insulin signaling by phosphorylation of key signaling molecules, such as the insulin receptor or IRS proteins (Morino et al., 2006; Vallerie and Hotamisligil, 2010).”
BackgroundHirabara, S. M., Curi, R., & Maechler, P. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21936 · Cited by 215
“These patients also show decreased mitochondrial density in skeletal muscle (Morino et al., 2006).”
BackgroundDapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Daniele, G., Xiong, J., Solis-Herrera, C., Merovci, A., Eldor, R., Tripathy, D., DeFronzo, R. A., Norton, L., & Abdul-Ghani, M. (2016) · Diabetes Care · doi:10.2337/dc15-2688 · Cited by 213
Gao, C.-L., Zhu, C., Zhao, Y.-P., Chen, X.-H., Ji, C.-B., Zhang, C.-M., Zhu, J.-G., Xia, Z.-K., Tong, M.-L., & Guo, X.-R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.039 · Cited by 204
Angiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernandez, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202
Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise
Safdar, A., & Tarnopolsky, M. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029827 · Cited by 203
“Mitochondrial dysfunction (including attenuated mitochondrial biogenesis, reduced mitochondrial content, and/or lower oxidative capacity) in skeletal muscle contributes to various aspects of metabolic syndrome, likely because of the pathological accumulation of intracellular lipids and lipid intermediates that inhibit…”
BackgroundInfluentialHenstridge, D. C., Bruce, C. R., Drew, B. G., Tory, K., Kolonics, A., Estevez, E., Chung, J., Watson, N., Gardner, T., Lee-Young, R. S., et al. (2014) · Diabetes · doi:10.2337/db13-0967 · Cited by 201
“Apart from the role of excess ectopic lipid accumulation, it has become apparent that insulin resistance may also be associated with defective oxidative metabolism in skeletal muscle (5).”
BackgroundEmerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance
Molina, M. N., Ferder, L., & Manucha, W. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0615-4 · Cited by 199
Chen, Y.-K., Cheung, C., Reuhl, K. R., Liu, A. B., Lee, M.-J., Lu, Y.-P., & Yang, C. S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2029016 · Cited by 195
“A possible molecular mechanism for hepatic steatosis induced hepatic insulin resistance is that accumulated of hepatocellular diacylglycerol activates protein kinase C-epsilon which catalyzes serine/threonine phosphorylation, resulting in reduced insulin-stimulated tyrosine phosphorylation, of the insulin receptor sub…”
BackgroundRangwala, S. M., Wang, X., Calvo, J. A., Lindsley, L., Zhang, Y., Deyneko, G., Beaulieu, V., Gao, J., Turner, G., & Markovits, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125401 · Cited by 190
Role of carnitine and its derivatives in the development and management of type 2 diabetes
Bene, J., Hadzsiev, K., & Melegh, B. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0017-1 · Cited by 186
The Relationship between Metabolic Syndrome and Osteoporosis: A Review
Wong, S., Chin, K.-Y., Suhaimi, F., Ahmad, F., & Ima-Nirwana, S. (2016) · Nutrients · doi:10.3390/nu8060347 · Cited by 186
Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD
Afshinnia, F., Rajendiran, T. M., Soni, T., Byun, J., Wernisch, S., Sas, K. M., Hawkins, J., Bellovich, K., Gipson, D., Michailidis, G., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030350 · Cited by 183
Dumas, M., Kinross, J., & Nicholson, J. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.001 · Cited by 187
Toward a unifying hypothesis of metabolic syndrome
Bremer, A. A., Mietus-Snyder, M., & Lustig, R. H. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2912 · Cited by 186
Vitamin D Status and Its Relation to Muscle Mass and Muscle Fat in Young Women
Gilsanz, V., Kremer, A., Mo, A. O., Wren, T. A. L., & Kremer, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2309 · Cited by 181
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Larter, C. Z., Chitturi, S., Heydet, D., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06253.x · Cited by 180
Long, Y. C., Cheng, Z., Copps, K. D., & White, M. F. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-10 · Cited by 180
“Many studies suggest that metabolic disease, including diabetes, originates from dysregulated skeletal muscle insulin action (45, 48).”
BackgroundSkeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
“been proposed to mediate the insulin resistance is a decrease in the capacity to oxidize fat, resulting in accumulation of intramuscular lipids (2, 10, 11).”
BackgroundFrailty and muscle metabolism dysregulation in the elderly
Evans, W. J., Paolisso, G., Abbatecola, A. M., Corsonello, A., Bustacchini, S., Strollo, F., & Lattanzio, F. (2010) · Biogerontology · doi:10.1007/s10522-010-9297-0 · Cited by 173
“IR-linked myosteatosis is most probably explained by a mitochondrial defect leading to failure in the use of intracellular fat, or from an increase in circulating triglycerides, or from reduced levels of physical activity (Morino et al. 2006).”
BackgroundGusdon, A. M., Song, K.-X., & Qu, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/637027 · Cited by 168
“One early hypothesis proposed that an accumulation of hepatic lipids in combination with decreased mitochondrial beta-oxidation of fatty acids reroutes these fatty acids toward the production of diacylglycerol and ceramide [118–122] resulting in the induction of stress induced kinases and subsequently impaired insulin…”
Mitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases
Theurey, P., & Rieusset, J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.002 · Cited by 176
Kunz, H., Hart, C. R., Gries, K. J., Parvizi, M., LAURENTI, M. C., Man, C. D., Moore, N., Zhang, X., Ryan, Z., Polley, E. C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00070.2021 · Cited by 188
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Wang, X., & Shapiro, J. I. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0101-8 · Cited by 161
Metadata
- Authors
- Morino, K., Petersen, K. F., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 55
- Issue
- Supplement_2
- Pages
- S9-S15
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2995546
- OpenAlex
- W2114416343
- Cited by
- 853
- References
- 91
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 29 · 2023: 35 · 2022: 26 · 2021: 28 · 2020: 48 · 2019: 38 · 2018: 42 · 2017: 39 · 2016: 60 · 2015: 34 · 2014: 53 · 2013: 54 · 2012: 63
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- U.S. Public Health Service (P30 DK45735, R01 DK-40936, R01 AG23686)
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, U24DK59635, P01 DK-063229, R01DK040936, U24DK059635, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, mitochondrial dysfunction, insulin-stimulated glucose transport, muscle glycogen synthesis, intramyocellular lipid, fatty acyl-CoA, diacylglycerol, protein kinase C epsilon, IRS-1, insulin receptor substrate 2, hepatic insulin resistance, non-alcoholic fatty liver disease, mitochondrial density, magnetic resonance spectroscopy
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Liver, Mitochondria, Muscle, Muscles, Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.